Related Experiment Video
Updated: Jul 24, 2026
08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Moderate hypofractionation for prostate cancer: A user's guide.
David I Pryor1,2, Sandra L Turner3,4, Keen Hun Tai5,6
1Princess Alexandra Hospital, Brisbane, Queensland, Australia.
Journal of Medical Imaging and Radiation Oncology
|January 17, 2018
Summary
Moderate hypofractionation is non-inferior to conventional fractionation for localized prostate cancer, showing similar disease control and toxicity. Patient selection and technique optimization are key for future moderately hypofractionated radiation therapy.
Area of Science:
- Oncology
- Radiation Oncology
Background:
- Recent large randomized controlled trials (RCTs) and phase 2 studies have evaluated moderate hypofractionation for localized prostate cancer.
- Mature follow-up data are now available, providing insights into long-term outcomes.
Purpose of the Study:
- To review the evidence supporting moderate hypofractionation for localized prostate cancer.
- To discuss patient selection criteria and implementation strategies for moderately hypofractionated radiation therapy.
Main Methods:
- Analysis of data from three large RCTs published within the last year.
- Review of mature follow-up data from phase 2 studies.
Main Results:
- Moderate hypofractionation demonstrated non-inferiority to conventional fractionation regarding disease control and late toxicity at 5 years.
- No clinically significant differences in patient-reported outcomes were observed.
- Phase 2 studies confirm low rates of significant toxicity at 10 years with moderate hypofractionation.
Conclusions:
- Moderate hypofractionation is a safe and effective treatment option for localized prostate cancer.
- Future treatment decisions will likely emphasize patient selection, androgen deprivation integration, and technique optimization over minor dose-fractionation variations.
- Guidelines for implementing moderately hypofractionated radiation therapy in clinical practice are needed.
